Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
The Journal of Nervous and Mental Disease|March 30, 2013
Consenting not to be informed: a survey on the acceptability of placebo use in the treatment of depressionUri Nitzan, Kfir Feffer, Yuval Bloch, et al.Journal of Clinical Nursing|April 30, 2022
Medical cannabis and stigma: A qualitative study with patients living with chronic painAmany Hulaihel, Or Gliksberg, Daniel Feingold, et al.Journal of Dual Diagnosis|November 1, 2016
State of Training, Clinical Services, and Research on Dual Disorders Across France, India, Israel, and SpainYatan Pal Singh Balhara, Shaul Lev-Ran, José Martínez-Raga, et al.Addictive Behaviors|January 10, 2026
Problematic cannabis use and attachment insecurities as Joint predictors of Depression: Cross-Sectional and longitudinal modelsOr Gliksberg, Dvora Shmulewitz, Vera Skvirsky, et al.Journal of Gambling Studies|September 9, 2025
Gambling in the Shadow of War: Evidence of Increased Problem Gambling for Men with Difficulties in Emotional Regulation During a Mass TraumaUri Lifshin, Hagit Bonny-Noach, Vera Skvirsky, et al.Acta Haematologica|October 22, 2018
Medical Cannabis Use by Hodgkin Lymphoma Patients: Experience of a Single CenterNadav Sarid, Mor Zada, Shaul Lev-Ran, et al.Qualitative Health Research|July 30, 2025
A Qualitative Investigation Into the Experiences of Medicinal Cannabis Use Among Chronic Pain and PTSD Patients in IsraelOr Gliksberg, Amany Hulaihel, Sharon R Sznitman, et al.Frontiers in Psychiatry|April 27, 2026
Meaning in life and the mental health - addiction spiral: testing a unifying modelOr Gliksberg, Uri Lifshin, Yoav Ankri, et al.Stress and Health : Journal of the International Society for the Investigation of Stress|February 25, 2026
Substance and Behavioural Addictions Among Evacuees: Findings From Israeli Swords of Iron WarGabriella Rubin, Uri Lifshin, Vera Skvirsky, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 6, 2003
DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic studyGil Zalsman, Amos Frisch, Shaul Lev-Ran, et al.Pageof 10